Effect of Beta-Blockers on Mortality after Myocardial Infarction in Adults with COPD

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
Jennifer Quint, clinical lecturer in epidemiology at the London School of Hygiene and Tropical Medicine, and Liam Smeeth, professor of clinical epidemiology at the London School of Hygiene and Tropical Medicine, discuss their BMJ study of UK COPD patients who have experienced a first myocardial infarction and the impact of beta-blocker therapy on mortality.

Related Articles
Roche recently launched a point-of-care (POC) test that can help health care professionals accurately diagnose high-risk heart attack patients in just 12 minutes.
Studies have reported that up to half of patients discontinue prescribed therapies soon after hospital discharge.
High hospital readmission rates plague the health care system.
The FDA today approved The Medicines Company’s cangrelor (Kengreal), an intravenous antiplatelet medication that can prevent blood clots from forming in the coronary arteries.
Latest Issues
$auto_registration$